Immune checkpoint inhibitors therapy for solid organ malignancies after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Transplant Complications Working Party
Bone Marrow Transplant. 2024 Dec 13.
doi: 10.1038/s41409-024-02497-8.
Online ahead of print.
1 Department of Hematology, University Hospitals Leuven, Leuven, Belgium. [email protected].
2 EBMT Paris Study Office / CEREST-TC, INSERM UMR-S 938, Department of Hematology, Sorbonne University, Hôpital Saint Antoine, Paris, France.
3 EBMT Transplant Complications Working Party (TCWP), Paris, France.
4 Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
5 Department of Hematology, University Hospitals Leuven, Leuven, Belgium.
6 Department of Microbiology, Immunology, and Transplantation, KU Leuven, Leuven, Belgium.
7 Department of Hematology, Sorbonne University, Hôpital Saint Antoine, Paris, France.
8 Department for Stem Cell Transplantation, University Medical Centre Hamburg, Hamburg, Germany.
9 Division for Stem Cell Transplantation and Cellular Immunotherapy, Department of Medicine II, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany.
10 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
11 Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
14 Bone Marrow Transplantation Unit, Hematology department, Tel Aviv Sourasky Medical Centre, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
15 Radboud University Medical Centre, Nijmegen, Netherlands.
16 Comprehensive Cancer Centre, King's College London, London, UK.
17 Department of Hematology, Catalan Institute of Oncology, Hospital Duran i Reynals, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
18 Medical Clinic, Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
19 RM Gorbacheva Research Institute, First Pavlov State Medical University of St Petersburg, St Petersburg, Russian Federation.
20 Department of Hematology, University Hospital Centre Rijeka, and School of Medicine, University of Rijeka, Rijeka, Croatia.
21 Department of Public Health and Primary Care, ACCENT VV, KU Leuven - University of Leuven, Leuven, Belgium.